AGF US Market Neutral Anti-Beta Fund
BTAL
4 hedge funds and large institutions have $2.22M invested in AGF US Market Neutral Anti-Beta Fund in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
96% less capital inflows, than outflows
Capital inflows: $20.4K | Capital outflows: $467K
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$20.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICC Capital Management
Orlando,
Florida
|
-$409K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$56K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.16K |
BTAL Hedge Fund Activity: Q1 2015 in Review
4 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q1 2015, worth a combined $2.22M — down 19% from $2.74M a quarter earlier.
Fund positioning in BTAL was balanced in Q1 2015: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $20.4K. The largest seller was ICC Capital Management, cutting an estimated $409K.
- 4 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $2.22M of AGF US Market Neutral Anti-Beta Fund stock for Q1 2015, down 19% quarter-over-quarter.
- 1 fund opened new AGF US Market Neutral Anti-Beta Fund positions in Q1 2015 and 1 closed out, a net change of 0 holders.
- The largest AGF US Market Neutral Anti-Beta Fund buyer in Q1 2015 was Bank of America, an estimated $20.4K added.
- The largest AGF US Market Neutral Anti-Beta Fund seller in Q1 2015 was ICC Capital Management, an estimated $409K sold.
Based on aggregated 13F filings for Q1 2015.